US Patent Issued to APHARMA on Aug. 26 for "Use of ITIH1 as biomarker for detection of insulin resistance in diseases accompanied by impaired glucose tolerance" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,202, issued on Aug. 26, was assigned to APHARMA (Goyang-si, South Korea).

"Use of ITIH1 as biomarker for detection of insulin resistance in diseases accompanied by impaired glucose tolerance" was invented by Sang Geon Kim (Seoul, South Korea), Yeonseok Chung (Seoul, South Korea), Tae Hyun Kim (Seoul, South Korea) and Won Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a composition and method for the diagnosis of diseases accompanied by impaired glucose tolerance, comprising a material for ITIH1 detection. The composition and method according to the present application enable a relatively sensitive response even ...